Drugs
(XML - 16KB)Current Drug Shortages A - D
The information provided in this section is provided voluntarily by manufacturers. FDA cannot require firms to report the reason for shortage or duration of the shortage or any other information about shortages. FDA appreciates all information provided by manufacturers. We post information about shortages as soon as we receive it from the manufacturers. To report information about shortages or supply issues, manufacturers can send updates to drugshortages@fda.hhs.gov. Healthcare professionals and patients are also encouraged to notify us of shortages at drugshortages@fda.hhs.gov.
*Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012
Acetylcysteine Inhalation Solution
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 | 100 mg/mL; 30 mL vial (NDC 0409-3307-03) | Next delivery November | Please check with your wholesaler for available inventory. | Demand increase for the drug. | Revised 8/31/2012 |
| 200 mg/mL; 30 mL vial (NDC 0409-3308-03) | Next delivery November | ||||
| Roxane Laboratories 1-614-276-4000 | 200 mg/mL, 10 mL (NDC 00054-3028-02) | Roxane Laboratories has all acetylcysteine inhalation solution presentations on backorder and the company cannot provide an anticipate release date. Shortage per Manufacturer: Manufacturing Delay | Demand increase for the drug. | ||
| 200 mg/mL, 30 mL (NDC 00054-3026-02) | |||||
| American Regent/Luitpold 631-924-4000 | 100 mg/mL, 4 mL (NDC 00517-7504-25) | Unavailable | American Regent is currently not releasing Acetylcysteine inhalation solution. Shortage per Manufacturer: Unavailable | Other | Reverified 8/31/2012 |
| 100 mg/mL, 10 mL (NDC 00517-7510-03) | |||||
| 200 mg/mL, 4 mL (NDC 00517-7604-25) | |||||
| 200 mg/mL, 10 mL (NDC 00517-7610-03) | |||||
| 200 mg/mL, 30 mL (NDC 00517-7630-03) |
Alfentanil Injection (Initial Posting Date) - 1/23/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Akorn Pharmaceuticals 1-800-932-5676 | 0.5 mg/ml; 2ml ampule (NDC 17478-0067-02) | Readily available | Quota request filed. (Per manufacturer) Shortage per Manufacturer: | Other | Reverified 8/13/2012 |
| 0.5 mg/ml; 5ml ampule (NDC 17478-0067-05) | On backorder pending DEA quota authorization. (Per manufacturer) | ||||
| Hospira, Inc. Customer Service: 1-877-946-7747 | 500 mcg/mL; 2 mL amp (NDC 0409-2266-02) | Available | Please check your wholesaler for all available inventory.
Due to increased demand, could see intermittent supply issues over the next couple months, until stable inventory position is attained.
| Demand increase for the drug. | Revised 8/31/2012 |
| 500 mcg/mL; 5 mL amp (NDC 0409-2266-05) | Available |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Teva Pharmaceuticals 1-800-545-8800 | 250 mg/mL 4 mL vials (NDC 00703-9040-03) | Teva expects additional inventory to be available by the beginning of August. | Shortage per Manufacturer: Manufacturing delays | Demand increase for the drug. | Revised 8/17/2012 |
Bedford Customer Service 1-800-562-4797 | 250 mg/mL, 2 mL vials (NDC 55390-0226-02) | Unavailable | Bedford Laboratories has 500mg/2ml and 1gm/4ml available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. Availability of products is updated on the Bedford Laboratories website. Shortage per Manufacturer: Manufacturing delays | Discontinuation of the manufacture of the drug. | Revised- 4/10/2012 |
250 mg/mL, 4 mL vials (NDC 55390-0226-04) |
Amino Acid Products (Initial Posting Date) - 2/14/2012
For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition:
http://www.nutritioncare.org/Professional_Resources/Information_to_Use_in_the_Event_of_an_Intravenous_Amino_Acids_Shortage/
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | Aminosyn II 10%, Sulfite-free; 1 L bag (NDC 0409-4164-05) | Available
| Please check with your wholesaler for available inventory. Please see the Dear Customer Letter (PDF - 31KB) Shortage per Manufacturer: | Other | Revised 8/31/2012 |
| Aminosyn 10%, Sulfite-free; 500 mL bag (NDC 0409-4191-03) | |||||
| Aminosyn 8.5%, Sulfite-free; 500 mL bag (NDC 0409-4187-03) | |||||
| Aminosyn II 15%, Sulfite-free; 2 L bag (NDC 0409-7171-17) | |||||
| Aminosyn 10%, Sulfite-free, 1 L (NDC 0409-4191-05) | |||||
| Aminosyn II 10%, 500 mL, Sulfite-free (NDC 0409-4164-03) | |||||
| Aminosyn HBC 7%, 500 mL, Sulfite-free (NDC 0409-4168-03) | |||||
| Aminosyn 3.5%, sulfite-free, 1 L (NDC 0409-4196-05) | |||||
| Aminosyn 8.5%, sulfite-free, 500 mL (NDC 0409-4187-03) | |||||
| Aminosyn II 8.5%, sulfite-free, 500 mL (NDC 0409-4162-03) | |||||
| Aminosyn II 8.5% with electrolytes, sulfite-free, 500 mL (NDC 0409-4171-03) | |||||
| Aminosyn-PF 7%, sulfite-free, 500 mL (NDC 0409-4178-03) | |||||
| Aminosyn-PF 10%, 1000 mL, sulfite-free (NDC 0409-4179-05) | |||||
| Aminosyn RF 5.2%, 500 mL, sulfite-free (NDC 0409-4166-03) | |||||
| Aminosyn II 10%; 2 L bag (NDC 0409-7121-07) | Product being replaced by (NDC 0409-7172-17) | ||||
| B. Braun Medical Inc. Customer Service: 1-800-227-2862 | TrophAmine 6%, 500 mL (NDC 00264-9361-55) | All B. Braun Amino Acids are available. | BBraun may start allocation if demand starts to exceed their increased production plans. Shortage per Manufacturer:
| Other | Revised 6/15/2012 |
| TrophAmine 10%, 500 mL (NDC 00264-9361-55) | |||||
| FreAmine III 10%, 1000 mL (NDC 00264-9010-55) | |||||
| Specialty Amino Acid Solutions FreAmine HBC 6.9%, 750 mL (NDC 00264-9350-55) | |||||
| NephrAmine 5.4%, 250 mL (NDC 00264-1909-55) | |||||
| HepatAmine 8%, 500 mL (NDC 00264-9371-55) | |||||
| 15% Amino Acids Injection 1,000 mL (NDC 0264-3200-55) | |||||
Baxter Customer Service:
| Travasol 10%, 500 mL (NDC 00338-0644-03) | Travasol products available
Clinimix and Clinimix E products are available | Baxter is currently experiencing a backorder situation on all presentations of Prosol, Premasol and Clinisol due to unforeseen demand. Allocated availability continued through Nov. 2012. | Demand increase for the drug | Revised 8/23/2012 |
| Travasol 10%, 1000 mL (NDC 00338-0644-04) | |||||
| Travasol 10%, 2000 mL (NDC 00338-0644-06) | |||||
| Prosol 20%, 2000 mL, sulfite-free (NDC 00338-0499-06) | |||||
| Clinisol 15%, 500 mL, sulfite-free (NDC 00338-0502-03) | |||||
| Clinisol 15%, 2000 mL, sulfite-free (NDC 00338-0502-06) | |||||
| Premasol 6%, 500 mL, sulfite-free (NDC 00338-1131-03) | |||||
| Premasol 10%, 500 mL, sulfite-free (NDC 00338-1130-03) | |||||
| Premasol 10%, 1000 mL, sulfite-free (NDC 00338-1130-04) | |||||
| Premasol 10%, 2000 mL, sulfite-free (NDC 00338-1130-06) | |||||
| Hepatosol 8%, 500 mL (NDC 00338-0504-03) | |||||
| CLINIMIX sulfite-free (2.75%, 4.25%, 5.0% Amino Acid in Dextrose) Injections in 1000 mL and 2000 mL Containers | |||||
| CLINIMIX E sulfite-free (2.75%, 4.25%, 5.0% Amino Acid with Electrolytes in Dextrose with Calcium) Injections in 1000 mL and 2000 mL Containers |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Hospira, Inc. Customer Service: | 5 mEq/mL; 20 mL vial (NDC 0409-6043-01) | Company estimates a release date by 1Q 2013 | Please check with your wholesaler for available inventory. | Other | Revised 8/31/2012 |
Ammonul (sodium phenylacetate and sodium benzoate) Injection 10%/10% (9/18/2008)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Ucyclyd Pharma, Inc. 1-888-829-2593, or 1-800-900-6389 with a representative available 24 hours, seven days a week. | 50mL vial (NDC 62592-720-50) | Limited supplies continue to be available. | Please see attached Dear Healthcare Professional Letter (PDF - 25KB) for important safety information. | Other | Revised 4/26/2012 |
Amphetamine Mixed Salts, ER Capsules (updated 10/31/2011)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Shire Customer Service: 1-800-828-2088 Adderall XR capsules | 5 mg - 100 count (NDC 54092-0381-01) | Product availability for all dosage strengths is adequate. | Shortage per Manufacturer: API supply issues and uneven product distribution patterns. | Demand increase for the drug | |
| 10 mg - 100 count (NDC 54092-0383-01) | |||||
| 15 mg - 100 count (NDC 54092-0385-01) | |||||
| 20 mg - 100 count (NDC 54092-0387-01) | |||||
| 25 mg - 100 count (NDC 54092-0389-01) | |||||
| 30 mg - 100 count (NDC 54092-0391-01) | |||||
| Teva Customer Service (888)838-2872 | 5 mg - 100 count (NDC 00555-0790-02) | Teva continues to release product as it becomes available. | Shortage per Manufacturer: API supply issues | Demand increase for the drug | Reverified 8/17/2012 |
| 10 mg - 100 count (NDC 00555-0787-02) | Teva continues to release product as it becomes available. | ||||
| 15 mg - 100 count (NDC 00555-0791-02) | Teva continues to release product as it becomes available. | ||||
| 20 mg - 100 count (NDC 00555-0788-02) | Teva continues to release product as it becomes available. | ||||
| 25 mg - 100 count (NDC 00555-0792-02) | Teva continues to release product as it becomes available. | ||||
| 30 mg - 100 count (NDC 00555-0789-02) | Teva continues to release product as it becomes available. | ||||
| Global Customer Service: (215)558-4300 | 10 mg ,100 count (NDC 00115-1329-01) | All finished product strengths are currently available on an allocated basis. | Shortage per Manufacturer: Inadequate finished product supply to support current market demand | Demand increase for the drug | |
| 15 mg, 100 count (NDC 00115-1330-01) | |||||
| 20 mg, 100 count (NDC 00115-1331-01) | |||||
| 25 mg, 100 count (NDC 00115-1332-01) | |||||
| 30 mg, 100 count (NDC 00115-1333-01) |
Amphetamine Mixed Salts Immediate-Release Tablets (updated 1/12/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Sandoz Customer Service: 1-609-627-8500 | 5 mg tablets, 100 count (NDC 00185-0084-01) | All strengths are available. | Demand increase for the drug | Reverified 9/12/2012 | |
| 10 mg tablets, 100 count (NDC 00185-0111-01) | |||||
| 20 mg tablets, 100 count (NDC 00185-0401-01) | |||||
| 30 mg tablets, 100 count (NDC 00185-0404-01) | |||||
| CorePharma 1-800-850-2719 | 5 mg tablets, 100 count (NDC 64720-0130-10) | CorePharma is releasing product as it becomes available. | Shortage per Manufacturer: Increase in demand | Demand increase for the drug | |
| 10 mg tablets, 100 count (NDC 64720-0132-10) | |||||
| 20 mg tablets, 100 count (NDC 64720-0135-10) | |||||
| 30 mg tablets, 100 count (NDC 64720-0136-10) | |||||
| Teva Customer Service: 1-888-838-2872 | 5 mg tablets, 100 count (NDC 00555-0971-02) | Low inventory, possible backorders through September | Shortage per Manufacturer: API supply issues | Shortage an active ingredient | Revised 8/17/2012 |
| 7.5 mg tablets, 100 count (NDC 00555-0775-02) | Backorder through August | ||||
| 10 mg tablets, 100 count (NDC 00555-0972-02) | Low inventory, possible backorders through September | ||||
| 12.5 mg tablets, 100 count (NDC 00555-0776-02) | Teva supply is adequate to meet demand. | ||||
| 15 mg tablets, 100 count (NDC 00555-0777-02) | Teva supply is adequate to meet demand. | ||||
| 20 mg tablets, 100 count (NDC 00555-0973-02) | Low inventory, possible backorders through September | ||||
| 30 mg tablets, 100 count (NDC 00555-0974-02) | Low inventory, possible backorders through October | ||||
| Adderall, 5 mg tablets, 100 count (NDC 00555-0762-02) | Teva supply is adequate to meet demand. | ||||
| Adderall, 7.5 mg tablets, 100 count (NDC 00555-0763-02) | |||||
| Adderall, 10 mg tablets, 100 count (NDC 00555-0764-02) | |||||
| Adderall, 12.5 mg tablets, 100 count (NDC 00555-0765-02) | |||||
| Adderall, 15 mg tablets, 100 count (NDC 00555-0766-02) | |||||
| Adderall, 20 mg tablets, 100 count (NDC 00555-0767-02) | |||||
| Adderall, 30 mg tablets, 100 count (NDC 00555-0768-02) |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. 1-877-946-7747 | 50,000 units/mL, 2 mL ampule (NDC 61703-418-07) | Next delivery TBD | Shortage per Manufacturer: Change in manufacturing site | Other | Revised 8/31/2012 |
Atracurium besylate (updated 2/27/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Bedford Customer Service: 1-800-562-4797 | 10 mg/mL, 5 mL vial, single dose vial (NDC 55390-0102-05) | Bedford Laboratories has 50mg Inj SDV 5ml and 100mg Inj MDV 10ml available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. Availability of products is updated on the Bedford Laboratories website. Shortage per Manufacturer: | Discontinuation of the manufacture of the drug. | Revised 4/10/2012 | |
| 10 mL vial, multi-dose vial (NDC 55390-0103-10) | |||||
| 5 mL Novaplus vial, single dose vial (NDC 55390-0180-05) | |||||
| 10 mL Novaplus vial, multi-dose vial (NDC 55390-0179-10) | |||||
| Sagent Pharmaceticals 1-866-625-1618 | 10 mg/mL, 5 mL single dose vial, (NDC 25021-659-05) | On allocation | Products launched end of May, 2012. | Demand increase for the drug. | Reverified 9/10/2012 |
| 10 mg/mL, 10 mL multi-dose vial (NDC 25021-672-10) | On allocation |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Amphastar Pharmaceuticals Inc. Customer Service: 1-800-423-4136 | 0.1 mg/mL, 10 mL, Luer-Jet Prefilled Syringe
NDC 76329-3339-1 (old NDC 00548-3339-00) | Available | Other | Revised 8/14/2012 | |
| Hospira, Inc. Customer Service: 1-877-946-7747 | 0.1 mg/mL; 10 mL Ansyr syringe (NDC 0409-1630-10) | Available | Please check with your wholesaler for available inventory. Shortage per Manufacturer: | Other | Revised 8/31/2012 |
| 0.05 mg/mL; 5 mL Ansyr syringe (NDC 0409-9630-05) | Next delivery 1Q 2013 | ||||
| 0.1 mg/mL; 5 mL Lifeshield syringe (NDC 0409-4910-34) | Next delivery 1Q 2013 | ||||
| 0.1 mg/mL; 10 mL Lifeshield syringe (NDC 0409-4911-34) | Next delivery 1Q 2013 | ||||
| American Regent/Luitpold 1-800-645-1706 | 0.4 mg/mL, 0.5 mL ampule, package of 25 (NDC 00517-0805-25) | Unavailable | Shortage per Manufacturer: | Discontinuation of the manufacture of the drug. | Revised 8/31/2012 |
| 0.4 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-0401-25) | Unavailable | Shortage per Manufacturer: American Regent is currently not releasing Atropine Sulfate Injection 0.4 mg/mL, 1 mL single-dose vial | |||
| 1 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-1010-25) | Available | Please check with your wholesaler for available inventory. | |||
| 1 mg/mL, 1 mL ampule, package of 25 (NDC 00517-0101-25) | Unavailable | Shortage per Manufacturer: American Regent/Luitpold has discontinued manufacturing the ampoules | |||
| West-Ward Pharmaceuticals Customer Service: 1-800-631-2174 (Formerly a Baxter Product) | 0.4 mg/mL, 20 mL vial | West-Ward currently has limited quantities available.
Additional lots will also be manufactured and available in August 2012. |
Product will be made available as it is released. Shortage per Manufacturer: | Demand increase for the drug. | Revised 7/9/2012 |
Bacteriostatic 0.9% Sodium Chloride 
(Initial posting-9/10/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 | 20 mL vial (NDC 0409-1966-05) | Next delivery December | Please check with your wholesaler for available inventory. | Other | |
| 30 mL vial (NDC 0409-1966-07) | Next delivery September | ||||
| 10 mL vial (NDC 0409-1966-12) | Next delivery October | ||||
| APP 1-888-386-1300 | 30 mL MD Vial Glass (NDC # 63323-259-30) | Unavailable | Shortage per Manufacturer: | Demand increase for the drug | |
| 30 mL MD Vial Plastic (NDC # 63323-924-30) | Next delivery for October 2012 | ||||
| 10mL MD Vial Plastic (NDC # 63323-924-10) | Next delivery for October 2012 | ||||
Boniva (ibandronate sodium) Injection (Initial posting-6/6/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Genentech, Inc. Customer Service: 1-800-551-2231 | 3 mg/mL (single use syringe) Box of 1 (NDC 0004-0191-09 | Current backlog at the US distribution center expected to continue until early-October 2012. Please check with your wholesaler for available inventory. | Shortage per Manufacturer: | Other | Revised 8/23/2012 |
Bumetanide Injection (Initial posting-6/21/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 | 0.25mg/mL; 4mL (NDC 00409-1412-04) | Next delivery October | Drug product allocated to direct orders | Demand increase for the drug. | Revised 8/31/2012 |
| 0.25mg/mL; 10mL vial (NDC 00074-1412-10) | Next delivery September | ||||
| West-Ward Pharmaceuticals Customer Service: 1-800-631-2174 | Bumetanide Injection, USP (formerly a Baxter product) 0.25 mg/mL, 10 mL vial (NDC 0641-6007-10) | West-Ward has very limited quantities available for both presentations. Additional lots of each code are scheduled for production and units are expected to be available in the beginning of August 2012. Product will be made available as it is released. | Shortage per Manufacturer: Increase in product demand due to market supply issues. | Demand increase for the drug. | Revised 6/25/2012 |
| 0.25mg/mL, 4mL vial (NDC 00641-6008-10) | |||||
| Bedford Customer Service: 1-800-562-4797 | 0.25mg/mL, 2 mL vial (NDC 55390-0500-02) | Not available | Shortage per Manufacturer: Manufacturing delay | Discontinuation of the manufacture of the drug. | |
| 0.25mg/mL, 4 mL vial (NDC 55390-0500-05) | |||||
| 0.25mg/mL, 10 mL vial (NDC 55390-0500-10) |
Bupivacaine Hydrochloride Injection
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | APP has Sensorcaine (with & without Epinephrine) on intermittent back-order and the company is releasing product as it becomes available. Check Wholesaler Inventory. | Shortage per Manufacturer: | Demand increase for the drug. | Reverified 8/27/2012 | |
Hospira, Inc.
| 0.25%; 30 mL amp (NDC 0409-1158-01) | Next delivery September | Please check with your wholesaler for available inventory.
Shortage per Manufacturer: manufacturing delay | Other | Revised 8/31/2012 |
| 0.25%; 10 mL vial (NDC 0409-1159-01) | Next delivery October | ||||
| 0.25%; 30 mL vial (NDC 0409-1159-02) | Next delivery August | ||||
| 0.25%; 50 mL vial (NDC 0409-1160-01) | Available | ||||
| 0.5%; 10 mL vial (NDC 0409-1162-01) | Next delivery August | ||||
| 0.5%; 30 mL vial (NDC 0409-1162-02) | Next delivery October | ||||
| 0.5%; 50 mL vial (NDC 0409-1163-01) | Next delivery August | ||||
| 0.75%; 10 mL vial (NDC 0409-1165-01) | Next delivery October | ||||
| 0.75%; 30 mL vial (NDC 0409-1165-02) | Next delivery October | ||||
| 0.75% in Dex 8.25%; 2mL amp (NDC 0409--3613-01) | Next delivery September | ||||
| 0.5% w/epi 1:200,000; Carpujects (NDC 0409-7600-01) | Company estimates a release date by 2013 | ||||
| 0.25% w/epi 1:200,000; 10 mL vial (NDC 0409-9042-01) | Next delivery October | ||||
| 0.25% w/epi 1:200,000; 30 mL vial(NDC 0409-9042-17) | Available | ||||
| 0.25% w/epi 1:200,000; 50 mL (NDC 0409-9043-01) | Next delivery September | ||||
| 0.5% w/epi 1:200,000; 30 mL (NDC 0409-9045-17) | Available | ||||
| 0.5% w/epi 1:200,000; 50 mL (NDC 0409-9046-01) | Available | ||||
| 50 mg/20 mL Sterile pack amp (NDC 0409-4272-01) | Next delivery September | ||||
100mg/20mL Sterile pack amp (NDC 0409-4273-01) | Next delivery August |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Bedford 1-800-562-4797 | 1 mL vial (NDC 55390-0010-10) | Bedford has buprenorphine injection on back order and the company cannot estimate a release date. Shortage per Manufacturer: | Discontinuation of the manufacture of the drug. | ||
| Hospira 1-877-946-7747 | 1 mL Carpuject syringe (NDC 0409-2012-32 | Next delivery TBD | Shortage per Manufacturer: | Shortage of an active ingredient/Demand increase for the drug. | Revised 8/31/2012 |
| American Regent/Luitpold 1-800-645-1706 | 1 mL vial (NDC 00517-0725-05) | Unavailable | Shortage per Manufacturer: Currently not releasing. | Other | Reverified 8/31/2012 |
| Reckitt Benckiser 804-379-1090 Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01) | Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01) are available | Reckitt Benckiser has Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01) available.
| Other |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Hospira, Inc. | 1 mg/mL; 1 mL vial (NDC 0409-1623-01) | Next delivery October | Please check with your wholesaler for all available inventory.
| Demand increase for the drug | Revised 8/31/2012 |
2 mg/mL; 1 mL vial (NDC 0409-1626-01) | Available | ||||
2 mg/mL; 2 mL vial (NDC 0409-1626-02) | Available | ||||
| Bedford Customer Service: 1-800-562-4797 | 1 mg/mL 1 mL vial (NDC 55390-0183-01) | Bedford has all butorphanol presentations on back order and the company cannot estimate a release date. | Shortage per Manufacturer: Manufacturing delays | Discontinuation of the manufacture of the drug. | |
| 1 mg/mL 1 mL Novaplus vial (NDC 55390-0341-10) | |||||
| 2 mg/mL 1 mL vial (NDC 55390-0184-01) | |||||
| 2 mg/mL 2 mL vial (NDC 55390-0184-02) | |||||
| 2 mg/mL 1 mL Novaplus vial (NDC 55390-0342-10) | |||||
| 2 mg/mL 10 mL vial (NDC 55390-0185-10) |
Caffeine, anhydrous (125 mg/mL) and Sodium benzoate (125 mg/mL)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| American Regent/Luitpold: 631-924-4000 | 2 mL single-dose vial, package of 10 (NDC 00517-2502-10) | Unavailable | Currently not releasing. | Other | Reverified 8/31/2012 |
Caffeine and Ergotamine Tartrate Tablet (Initial Posting-3/8/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Sandoz Customer Service: 1-609-627-8500 | 100 mg caffeine/ 1 mg ergotamine tartrate; 100 count bottle (NDC 00781-5405-01 | Temporarily unavailable and Sandoz cannot estimate a release date. | Change in the raw material plant location, we will continue to provide updates as further information becomes available. | Shortage of an active ingredient. | Reverified 9/12/2012 |
Cardiolite, Kit for the Preparation of Technetium Tc99m Sestamibi for Injection (Initial Posting Date) – 5/4/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Lantheus Medical Imaging 1-800-299-3431 | 5 vial kit (NDC 11994-001-55) | Lantheus has limited supplies available and continue to release product as it becomes available. | Shortage per Manufacturer: Manufacturing delays at contract manufacturer and limited supply available from alternate contract manufacturer | Requirements related to complying with good manufacturing practices | Reverified 9/11/2012 |
| 20 vial kit (NDC 11994-001-20) |
Chloroprocaine (Nesacaine) Injection (Initial Posting 3/28/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 10 mg/mL with preservative, 30 mL vial, 25 count (NDC 63323-0475-37) | Available | Shortage per Manufacturer: | Demand increase for the drug. | Reverified 8/27/2012 |
| 20 mg/mL with preservative, 30 mL vial, 25 count (NDC 63323-0476-37) | Currently back-ordered | ||||
| 30 mg/mL preservative-free, 20 mL vials, 25 count (NDC 63323-0478-27) | Currently back-ordered | ||||
| Bedford Laboratories | 20 mg/mL preservative-free, 20 mL vials (NDC 55390-0403-20) | Bedford Laboratories is out of stock and the company cannot estimate a release date. | Production is pending as capacity permits. Availability of products is updated on the Bedford Laboratories website Shortage per Manufacturer: | Discontinuation of the manufacture of the drug | 3/28/2012 |
| 30 mg/mL preservative-free, 20 mL vials (NDC 55390-0404-20) |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service 1-877-946-7747 | 4 mcg/mL; 10 mL vial (NDC 0409-4093-01) | Next delivery December | Shortage per Manufacturer: Other manufacturer shortage/market withdrawal. | Demand increase for the drug. | Reverified 8/31/2012 |
| American Regent/Luitpold 1-800-645-1706 | SOL 4 mcg/ml INTRAVENOUS 10 ml 25s (NDC 00517-6310-25) | Unavailable | Currently not releasing | Other | Reverified 8/31/2012 |
Citric Acid; Gluconolactone; Magnesium Carbonate Solution; Irrigation (Initial posting– 6/30/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
United Guardian Customer Service: | Renacidin® Irrigation | Limited Availability | Shortage per Manufacturer: Manufacturing Delay | Other |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Ferring Pharmaceuticals, Inc. 1-888-Ferring (1-888-337-7464) | EQ 0.1 MG Base/Vial (NDC 55566-0302-1) | No stock available | Shortage per Manufacturer: Manufacturing delay | Other | Reverified 8/13/2012 |
Daunorubicin Hydrochloride Solution for Injection
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Teva Pharmaceuticals 1-800-545-8800 | 5 mg/mL, 4 mL single-dose vial (NDC 00703-5233-13) | Teva has daunorubicin available but the company is reviewing orders prior to release. | Shortage per Manufacturer: Increased Demand | Demand increase for the drug. | Reverified 8/17/2012 |
Bedford Customer Service | 5 mg/mL, 4 mL single-dose vial (NDC 55390-0108-10) | Available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. | Availability of products is updated on the Bedford Laboratories website Shortage per Manufacturer: | Discontinuation of the manufacture of the drug. | Revised 4/10/2012 |
| 10 mL single-dose vial (NDC 55390-0108-01) | |||||
| Cerubidine lyophilized powder for injection, 20mg single-dose vial, package of 10 (NDC 55390-0281-10) |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Ferring
| 4 mcg/mL 1ml vials (NDC 55566-5030-01) | Available | Shortage per Manufacturer: | Other | Reverified 8/13/2012 |
| 4mcg/mL 10ml (NDC 55566-5040-01) | Available | ||||
| Hospira Inc. Customer Service: 1-877-946-7747 | 4 mcg/mL, 1 mL amp (NDC 00409-2265-01) | Next delivery August | Please check with your wholesaler for available inventory. | Demand increase for the drug. | Reverified 8/31/2012 |
| Sanofi-Aventis 1-800-981-2491 | (DDAVP) 4 mcg/mL; 1 mL ampule (NDC 00075-2451-01) | Both presentations available. | Shortage per Manufacturer: Available | Other | Reverified 9/12/2012 |
| 4 mcg/mL; 10 mL vial (NDC 00075-2451-53) | |||||
Teva Pharmaceuticals
| 4mcg/mL, 4mcg (NDC 00703-5051-03) | All presentation on back order and the company cannot estimate a release date. | Shortage per Manufacturer: Manufacturing delays | Other | Reverified 8/17/2012 |
| 4mcg/mL, 40 mcg (NDC 00703-5054-01) |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Mylan Institutional 1-888-258-4199 | 250 mg vial (NDC 67457-0207-25) | Available from wholesalers | Demand increase for the drug. | Reverified 9/5/2012 | |
| 500 mg vial (NDC 67457-208-50) | |||||
| Pfizer Injectables 1-800-533-4535 http://www.pfizerinjectables.com/  | Pfizer has product available for both strengths. | Pfizer Injectables has available vials of 250 mg NDC (0013-8717-62), 500 mg (NDC 0013-8727-89). | Other | Reverified 6/25/2012 | |
| Topotarget USA, Inc. 1-973-895-6900 | Totect 500 mg (dexrazoxane) for injection (NDC 38423-110-01) | Topotarget USA has worked with the US Food and Drug Administration (FDA) to increase the availability of Totect Kits. Effective February 6, 2012, the FDA has approved the extension of the expiration date to 36 months for Totect Kits with following batch numbers:
Topotarget USA, Inc. has recently released additional 129 kits to help fill the back order for this product. The company cannot estimate a release for additional Totect Kits at this time. Shortage per Manufacturer: | Other | Revised 4/26/2012 |
Dextroamphetamine Tablets (1/12/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Teva Pharmaceuticals 1-888-838-2872 | 5 mg tablets, 100 count (NDC 00555-0952-02) | Available. | As of August 17, low inventory levels, however, no backorder or future projections of backorder. Improved inventory position expected by Q412.
Shortage per Manufacturer: | Other | Revised 8/17/2012 |
| 10 mg tablets, 100 count (NDC 00555-0953-02) | Available. Inventory will remain low until 4Q12. |
Dextrose Injection (Initial posting – 5/23/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. Customer Service: 1-800-423-4136 | 50%, 50mL Luer-Jet Prefilled Syringe
NDC 76329-3301-1 (old NDC 0548-3301-00) | Amphastar will regularly release products | Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues.
Shortage per Manufacturer: | Demand increase for the drug. | Reverified 8/14/2012 |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 5 mg/mL; 2 mL Carpuject (0409-1273-32) | Next delivery September | Shortage per Manufacturer: manufacturing delay | Other | Revised 8/31/2012 |
| 5 mg/mL; 10 mL vial (0409-3213-12) | Next delivery September |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| West-Ward Pharmaceuticals Customer Service: 1-888-229-0001 (Formerly a Baxter Product) | 250 mcg/mL, 2 mL ampuls (NDC 0641-1410-35) | West-Ward currently has available inventory. Production has been accelerated and additional lots are scheduled to be released in August 2012. | Product will be made available as it is released. Shortage per Manufacturer: | Demand increase for the drug. | Revised 7/9/2012 |
Covis Pharma S.à.r.l Customer Service: | Lanoxin Injection, USP 250 mcg/mL, 2 mL (10s - NDC 00173-0260-10) | Available | No longer on limited supply. Shortage per Manufacturer: | Other | Revised 6/13/2012 |
| Lanoxin Injection, USP 250 mcg/mL, 2 mL (50s - NDC 00173-0260-35) | Covis Pharma S.à.r.l has discontinued manufacturing Lanoxin Injection, USP 250 mcg/mL, 2 mL (50s - NDC 00173-0260-35). |
Dipyridamole Injection (Initial posting-7/24/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
West-Ward Pharmaceuticals Customer Service: | Dipyridamole Injection, USP 5 mg/mL; 10 mL vial | West-Ward is currently experiencing a backorder situation. West-Ward has increased production and is anticipating having product available in the middle of August 2012. Additional lots are projected to be available by the end of September 2012. Product will be made available as it is released. | Shortage per Manufacturer: Increase in product demand due to market supply issues. | Demand increase for the drug. |
|
Doxorubicin (adriamycin) lyophilized powder (updated 12/2/2011)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Bedford Laboratories Customer Service 1-800-562-4797 | 10 mg vials (NDC 55390-0231-01) | Bedford Laboratories has 10 mg available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. Other presentations are pending release with release date yet to be determined. | Availability of products is updated on the Bedford Laboratories website. Shortage per Manufacturer: | Discontinuation of the manufacture of the drug. | Revised 4/10/2012 |
| 20 mg vials (NDC 55390-0232-10) | |||||
| 50 mg vials (NDC 55390-0233-01) |
Doxorubicin Liposomal (Doxil) Injection
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Janssen Products, LP (formerly Centocor Ortho Biotech Products, L.P.) 1-800-526-7736 (1-800-JANSSEN) | Doxil 2 mg/mL, Janssen Products, LP 2 mg/mL, 10 mL (20 mg) vial (NDC 59676-0960-01) | Please see http://www.doxil.com/sites/default/files/DHCP_september2011.pdf
Shortage per Manufacturer: | Other | ||
| Sun Pharma Global FZE (Caraco Pharmaceutical, U.S. distributor) 1-888-835-2237 | Lipodox (10 ml): NDC 47335-082-50 | Available | Sun Pharma Global FZE, and its authorized distributor, Caraco Pharmaceutical Laboratories Ltd, in conjunction with the FDA, are initiating a temporary importation of Lipodox (doxorubicin HCL liposomal for injection), into the United States market to address this shortage. Please see the Dear Healthcare Professional Letter (PDF - 65KB) for information about supplies that are now available to help address the current shortage.
| Other | Revised 6/20/2012 |
| Lipodox 50 (25 ml): NDC 47335-083-50 |
